Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
J Low Genit Tract Dis ; 25(3): 236-242, 2021 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-34016868

RESUMEN

OBJECTIVE: The purpose of this study was to compare techniques and pain scales that assess tenderness in the vulvar vestibule in provoked vestibulodynia, using the cotton swab test and a vulvalgesiometer, and assess topical lidocaine solution with each. MATERIALS AND METHODS: This randomized study at a specialty vulvar clinic evaluated tender vestibules of reproductive-aged women with vestibulodynia using light rolling cotton swab touch at 6 sites and evaluated the vulvalgesiometer at 2 sites, randomizing the order of the initial tool. Participants reported pain using the Numerical Rating Scale 0-10 and the Verbal Pain Scale 0-3. With the vulvalgesiometer, the pain tolerance threshold was measured using forces of 10, 25, 50, 100, 200, and 300 g. After both initial tests, lidocaine 4% topical solution was applied for 3 minutes, and the swab test and vulvalgesiometer were repeated in the order initially performed, constituting the lidocaine test. Data analysis used t tests, Fisher exact tests, Wilcoxon signed rank tests, and Spearman rank correlation. RESULTS: Sixteen patients completed the study, 8 starting with each instrument. Light swab touch evoked significant pain, and lidocaine reduced pain to zero or mild levels. The pain threshold was 25 g, and only 38% could tolerate testing past 100 g without lidocaine. The Verbal Pain Scale correlated well with the Numerical Rating Scale. CONCLUSIONS: Light rolling cotton swab touch using the 4-item verbal scale can map vestibulodynia tenderness that can be extinguished by lidocaine, consistent with distinguishing a mucosal condition. Forces by vulvalgesiometer of greater than 100-200 g may evoke pain other than mucosal allodynia.


Asunto(s)
Anestésicos Locales/farmacología , Lidocaína/farmacología , Dolor/tratamiento farmacológico , Vulva/efectos de los fármacos , Vulvodinia/tratamiento farmacológico , Adulto , Femenino , Humanos , Oregon , Dolor/psicología , Dimensión del Dolor , Tacto/efectos de los fármacos , Vulvodinia/psicología , Adulto Joven
2.
J Low Genit Tract Dis ; 22(4): 412-414, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-30074956

RESUMEN

Periclitoral masses are uncommon disorders in gynecology often leading to pain and distress. With the popularity of female genital hair grooming and depilation, the vulva has been exposed to new insults including contact dermatitis and folliculitis. The unique anatomy of the protective covering of the clitoral hood may subject hair fragments to trapping, inflammation, irritation, and in some cases abscess formation.


Asunto(s)
Dermatitis por Contacto/diagnóstico , Dermatitis por Contacto/patología , Foliculitis/diagnóstico , Foliculitis/patología , Remoción del Cabello/efectos adversos , Piel/patología , Vulva/patología , Adolescente , Adulto , Femenino , Humanos , Persona de Mediana Edad , Adulto Joven
3.
BMC Infect Dis ; 8: 93, 2008 Jul 16.
Artículo en Inglés | MEDLINE | ID: mdl-18631397

RESUMEN

BACKGROUND: Reasons for the variation in reported treatment outcomes from antiretroviral therapy (ART) programmes in developing countries are not clearly defined. METHODS: Among ART-naïve individuals in a workplace ART programme in South Africa we determined virological outcomes at 12 months, and risk factors for suboptimal virological outcome, defined as plasma HIV-1 viral load > or = 400 copies/ml. RESULTS: Among 1760 individuals starting ART before July 2004, 1172 were in follow-up at 12 months of whom 953 (81%) had a viral load measurement (median age 41 yrs, 96% male, median baseline CD4 count 156 x 10(6)/l). 71% (681/953) had viral load < 400 copies/ml at 12 months. In a multivariable analysis, independent predictors of suboptimal virological outcome at 12 months were <1 log decrease in viral load at six weeks (odds ratio [OR] 4.71, 95% confidence interval [CI] 2.56-8.68), viral load at baseline (OR 3.63 [95% CI 1.88-7.00] and OR 3.54 [95% CI 1.79-7.00] for 10,001-100,000 and >100,000 compared to < or = 10,000 copies/ml, respectively), adherence at six weeks (OR 3.50 [95% CI 1.92-6.35]), WHO stage (OR 2.08 [95% CI 1.28-3.34] and OR 2.03 [95% CI 1.14-3.62] for stage 3 and 4 compared to stage 1-2, respectively) and site of ART delivery. Site of delivery remained an independent risk factor even after adjustment for individual level factors. At 6 weeks, of 719 patients with self-reported adherence and viral load, 72 (10%) reported 100% adherence but had <1 log decrease in viral load; conversely, 60 (8%) reported <100% adherence but had > or = 1 log decrease in viral load. CONCLUSION: Virological response at six weeks after ART start was the strongest predictor of suboptimal virological outcome at 12 months, and may identify individuals who need interventions such as additional adherence support. Self reported adherence was less strongly associated but identified different patients compared with viral load at 6 weeks. Site of delivery had an important influence on virological outcomes; factors at the health system level which influence outcome need further investigation to guide development of effective ART programmes.


Asunto(s)
Antirretrovirales/uso terapéutico , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/virología , VIH-1 , Servicios de Salud del Trabajador/estadística & datos numéricos , Adulto , Anciano , Estudios de Cohortes , Femenino , Infecciones por VIH/sangre , Infecciones por VIH/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Cooperación del Paciente/estadística & datos numéricos , ARN Viral/sangre , Factores de Riesgo , Sudáfrica , Lugar de Trabajo
4.
Obstet Gynecol Clin North Am ; 44(3): 493-508, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28778645

RESUMEN

Vulvodynia is a common condition that negatively affects sexual health and quality of life for many women. A new classification system has been adopted that divides vulvodynia into subtypes based on pain characteristics. Diagnosis relies on ruling out possible contributing pathologic conditions. A multidisciplinary approach to treatment is likely to achieve the best outcome for all types. Medical therapy with systemic neuromodulators is suggested for generalized vulvodynia. For patients with vestibulodynia, topical therapy may be beneficial. Vestibulectomy has a high success rate and may be a good option if the patient is not responding to treatment.


Asunto(s)
Vulvodinia , Femenino , Humanos , Vulvodinia/diagnóstico , Vulvodinia/etiología , Vulvodinia/terapia
5.
J Womens Health (Larchmt) ; 19(11): 2101-7, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20849297

RESUMEN

Reproductive health research in low-resource settings poses unique and complex challenges that must be addressed to ensure that global research is conducted with strict adherence to ethical principles, offers direct benefit to the research subjects, and has the potential for adoption of positive findings to the target population. This article addresses challenges to conducting reproductive health research in low-resource settings in the following areas: (1) establishment and maintenance of global collaboration, (2) community partnerships, (3) ethical issues, including informed consent and the role of incentives, (4) staff training and development, (5) data collection and management, and (6) infrastructure and logistics. Particular attention to these challenges is important to ensure that research is culturally appropriate and methodologically sound and enhances the adoption of health-promoting behaviors. Rigorous evaluation of interventions in low-resource settings may be a cost-effective and time-efficient way to identify interventions for large-scale program replication to improve women's health.


Asunto(s)
Salud Global , Investigación sobre Servicios de Salud/organización & administración , Cooperación Internacional , Medicina Reproductiva , Participación de la Comunidad , Países en Desarrollo , Investigación sobre Servicios de Salud/ética , Investigación sobre Servicios de Salud/normas , Humanos , Consentimiento Informado , Desarrollo de Personal
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA